Life Science News

Al Bawaba reported that Saudi Arabia’s pharmaceutical market is very healthy and is estimated to grow 4.7 percent annually, reaching $4.7 billion by 2016.

Al Bawaba reported that Saudi Arabia’s pharmaceutical market is very healthy and is estimated to grow 4.7 percent annually, reaching $4.7 billion by 2016.

As quoted in the market news:

The primary drivers behind this shift include expiring patents and generic competition, pricing pressures, heightened regulatory scrutiny, expansion into emerging markets, increasing alliances and acquisitions, and a persistent economic slowdown, the report said.

“To grow in this challenging climate, the life sciences industry is transitioning away from a primary-care, small-molecule-driven sales model, towards targeting specialist secondary care indications,” said Herve Ballantyne, healthcare industry leader, Deloitte Middle East.

Click here to read the full Al Bawaba report.

MARKETS

Markets
TSX19062.91+345.79
TSXV647.33+15.54
DOW31500.68+823.32
S&P 5003911.74+116.01
NASD11607.62+375.43
ASX6528.40+19.90

COMMODITIES

Commodities
Gold1827.54+0.47
Silver21.15+0.03
Copper3.740.00
Palladium1879.51+6.50
Platinum911.26+4.32
Oil107.06+2.79
Heating Oil4.24+0.02
Natural Gas6.17-0.07

DOWNLOAD FREE REPORTS

×